KIMS Hospitals Q2 operating revenue climbs 40%, margin narrows

Krishna Institute of Medical Sciences Limited reported Q2 FY27 revenue from operations of Rs 1,344.4 crore, up 39.9% year on year, while EBITDA before Ind AS adjustments and other income rose 17.9% to Rs 231.6 crore and its corresponding margin declined to 17.2% from 20.5% a year earlier.

What did KIMS Hospitals report for Q2 FY27?

KIMS Hospitals reported total income of Rs 1,363.0 crore for Q2 FY27, up 41.3% from Rs 964.9 crore in Q2 FY26 and 14.0% from Rs 1,195.9 crore in Q1 FY27. Revenue from operations was Rs 1,344.4 crore, compared with Rs 960.7 crore a year earlier and Rs 1,179.5 crore in the preceding quarter.

Other income was Rs 18.6 crore in Q2 FY27, compared with Rs 4.2 crore in Q2 FY26 and Rs 16.4 crore in Q1 FY27. This distinction separates total income from operating revenue and from the company's measure of EBITDA excluding other income. KIMS Hospitals' board approved the results on 4 November 2026 for the quarter ended 30 September 2026.

How did KIMS Hospitals' profitability change?

KIMS Hospitals reported earnings before interest, tax, depreciation and amortisation, or EBITDA, of Rs 278.9 crore in Q2 FY27, up 34.0% year on year and 16.3% quarter on quarter. The reported EBITDA margin was 20.5%, versus 21.7% in Q2 FY26 and 20.1% in Q1 FY27.

KIMS Hospitals' EBITDA before Indian Accounting Standards, or Ind AS, adjustments and excluding other income was Rs 231.6 crore, versus Rs 196.5 crore in Q2 FY26 and Rs 205.7 crore in Q1 FY27. This measure grew more slowly than the 39.9% increase in operating revenue, and its margin fell to 17.2% from 20.5% a year earlier and 17.4% in the preceding quarter. Ind AS adjustments were Rs 28.7 crore, compared with Rs 7.5 crore in Q2 FY26.

Profit before tax was Rs 106.6 crore, 10.1% above Rs 96.8 crore in Q2 FY26 and 88.3% above Rs 56.6 crore in Q1 FY27. KIMS Hospitals said this figure includes the gain on fair valuation of a call option, the statutory impact of new labour codes and share of profit from an associate; exceptional items were Rs 13.2 crore in Q2 FY27.

For FY26, revenue from operations was Rs 3,904.6 crore against Rs 3,035.1 crore in FY25, while EBITDA before Ind AS adjustments and excluding other income was Rs 758.4 crore versus Rs 759.0 crore. The corresponding annual margin was 19.4% in FY26, compared with 25.0% in FY25.

Did KIMS Hospitals' patient volumes and patient revenue increase?

KIMS Hospitals recorded inpatient volume of 81,668 in Q2 FY27, up 27.0% from 64,288 in Q2 FY26 and 12.7% from 72,493 in Q1 FY27. Outpatient volume rose 23.3% year on year to 7,31,010 and increased 11.0% from 6,58,617 in the preceding quarter.

Average revenue per occupied bed, or ARPOB, was Rs 48,277, up 14.9% year on year from Rs 42,016 and 2.3% sequentially from Rs 47,200. Average revenue per patient, or ARPP, was Rs 1.65577 lakh, rising 9.9% from Rs 1.50624 lakh in Q2 FY26 and 1.2% from Rs 1.63573 lakh in Q1 FY27.

The operational data show both higher activity and higher reported revenue measures per occupied bed and per patient during Q2 FY27. On an annual basis, FY26 inpatient volume was 2,46,297, up 15.4% from 2,13,346 in FY25, while outpatient volume increased 25.4% to 23,00,360.

What were KIMS Hospitals' profit and cash figures?

KIMS Hospitals reported profit after tax of Rs 76 crore in Q2 FY27, compared with Rs 72 crore in Q2 FY26 and Rs 37 crore in Q1 FY27. Consolidated earnings per share were Rs 1.8 for the period ended 30 September 2026, representing 8.5% year-on-year growth according to the release.

KIMS Hospitals held Rs 420 crore in cash and cash equivalents as of 30 September 2026, including cash, bank balances, deposits maturing in less than 12 months and mutual-fund investments. Interest was Rs 65.5 crore in Q2 FY27, lower than Rs 83.4 crore in Q1 FY27 but above Rs 45.0 crore in Q2 FY26, while depreciation was Rs 120.7 crore.

What clinical milestones did KIMS Hospitals disclose in Q2 FY27?

KIMS Hospitals said its Secunderabad unit performed 300 robotic surgeries using the Da Vinci XI system by Q2 FY27. The release also described extracorporeal membrane oxygenation support for a 32-year-old patient with severe acute respiratory distress syndrome, followed by 25 days of intensive treatment and rehabilitation.

KIMS Hospitals said its Icon unit in Visakhapatnam performed its first awake brain-tumour surgery on a 25-year-old woman, who was discharged on day five without reported deficits. At KIMS Savera in Anantapur, a 22-year-old patient received a 16 x 60 millimetre metallic Y-stent during emergency rigid bronchoscopy and was taken off ventilator support the next day.

Conclusion

KIMS Hospitals produced 39.9% year-on-year growth in Q2 FY27 operating revenue to Rs 1,344.4 crore as inpatient volume rose 27.0%, outpatient volume rose 23.3%, and ARPOB and ARPP increased. Underlying EBITDA rose at a slower 17.9% pace to Rs 231.6 crore, reducing its margin by 3.3 percentage points year on year to 17.2%.

The release does not give a margin target or explain the factors behind the decline in underlying EBITDA margin. The unresolved issue for subsequent disclosures is whether operating revenue growth, patient volumes, ARPOB and ARPP continue to outpace underlying EBITDA growth, alongside movements in the Rs 420 crore cash-and-cash-equivalents balance reported at 30 September 2026.